Science Explorer Interactive view Map
Company · Covington · United States

Bexion Pharmaceuticals (United States)

bexionpharma.comROR OpenAlex
Research works
18
▲ 733% vs 2013–17
Citations
37
2.1 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
43%
world 28%

Not ranked overall: Bexion Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.92× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 3.88× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 6.81× its world share, 0 worksPharmacology, Toxico…Engineering: 0.29× its world share, 0 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.13× its world share, 0 worksMaterials ScienceMedicine: 3.05× its world share, 6 worksMedicineVeterinary: 2.12× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.8×. Every wedge is a field page.

Which research topics does Bexion Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Sphingolipid Metabolism and Signaling, Natural Antidiabetic Agents Studies, Autophagy in Disease and Therapy and Radiomics and Machine Learning in Medical Imaging.

Sphingolipid Metabolism and Signaling: 1 fractional worksNatural Antidiabetic Agents Studies: 1 fractional worksAutophagy in Disease and Therapy: 1 fractional worksRadiomics and Machine Learning in Medical Imaging: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksATP Synthase and ATPases Research: 0 fractional worksBlood Pressure and Hypertension Studies: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksNanoplatforms for cancer…0Nanoplatforms for cancer theranostics: 0 fractional works
Molecular BiologyEndocrinology, Diabetes and MetabolismEpidemiologyRadiology, Nuclear Medicine and Imaging4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Sphingolipid Metabolism and Signaling Molecular Biology 1 works
  2. 2 Natural Antidiabetic Agents Studies Endocrinology, Diabetes and Metabolism 1 works
  3. 3 Autophagy in Disease and Therapy Epidemiology 1 works
  4. 4 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 ATP Synthase and ATPases Research Molecular Biology 0 works
  8. 8 Blood Pressure and Hypertension Studies Cardiology and Cardiovascular Medicine 0 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
  10. 10 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.2%not open56.8%

World: 28% of research is openly available.

with international co-authors10.9%domestic only89.1%

World: 19% is written across borders.

How has Bexion Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 733% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Covington

All research institutions in Covington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.